Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling"
NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL123404, R01 HL096686]
第一作者机构：[1]Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China;
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China;
推荐引用方式(GB/T 7714)：
Du Jie,Ma Xin-liang,Li Yulin,et al.Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling"[J].CIRCULATION.2017,136(21):2094-2095.doi:10.1161/CIRCULATIONAHA.117.030421.
APA：
Du, Jie,Ma, Xin-liang,Li, Yulin&Chen, Boya.(2017).Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".CIRCULATION,136,(21)
MLA：
Du, Jie,et al."Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling"".CIRCULATION 136..21(2017):2094-2095
医学